APA

Nielsen L. B., Mortensen H. B., Chiarelli F., Holl R., Swift P., de Beaufort C., Pociot F., Hougaard P., Gammeltoft S., Knip M. & Hansen L. (20061024). Impact of IDDM2 on disease pathogenesis and progression in children with newly diagnosed type 1 diabetes: reduced insulin antibody titres and preserved beta cell function. : Diabetologia.

Chicago

Nielsen L B, Mortensen H B, Chiarelli F, Holl R, Swift P, de Beaufort C, Pociot F, Hougaard P, Gammeltoft S, Knip M and Hansen L. 20061024. Impact of IDDM2 on disease pathogenesis and progression in children with newly diagnosed type 1 diabetes: reduced insulin antibody titres and preserved beta cell function. : Diabetologia.

Harvard

Nielsen L. B., Mortensen H. B., Chiarelli F., Holl R., Swift P., de Beaufort C., Pociot F., Hougaard P., Gammeltoft S., Knip M. and Hansen L. (20061024). Impact of IDDM2 on disease pathogenesis and progression in children with newly diagnosed type 1 diabetes: reduced insulin antibody titres and preserved beta cell function. : Diabetologia.

MLA

Nielsen L B, Mortensen H B, Chiarelli F, Holl R, Swift P, de Beaufort C, Pociot F, Hougaard P, Gammeltoft S, Knip M and Hansen L. Impact of IDDM2 on disease pathogenesis and progression in children with newly diagnosed type 1 diabetes: reduced insulin antibody titres and preserved beta cell function. : Diabetologia. 20061024.